Table 2.
ITEM | Treatments | SEM | p-Value | ||||||
---|---|---|---|---|---|---|---|---|---|
CON | BGL | ECON | EBGL | BGL | ETEC | Interaction | |||
Duodenum | MDA (nmol/mL) | 1.03 ab | 0.69 b | 1.51 a | 0.79 b | 0.12 | 0.03 | 0.20 | 0.39 |
T-AOC (U/mL) | 0.48 | 0.42 | 0.4 | 0.49 | 0.03 | 0.79 | 0.92 | 0.21 | |
GSH-PX (U) | 175.95 a | 184.42 a | 139.72 b | 163.59 ab | 6.60 | 0.19 | 0.03 | 0.53 | |
CAT (U/mL) | 81.95 ab | 75.01 b | 62.86 b | 103.76 a | 4.84 | 0.55 | 0.046 | <0.01 | |
T-SOD (U/mL) | 123.57 ab | 110.63 b | 136.51 a | 115.02 ab | 3.34 | <0.01 | 0.14 | 0.46 | |
Jejunum | MDA (nmol/mL) | 1.03 ab | 0.8 ab | 1.36 a | 0.67 b | 0.1 | 0.04 | 0.77 | 0.16 |
T-AOC (U/mL) | 0.57 a | 0.43 ab | 0.30 b | 0.44 ab | 0.03 | 0.99 | 0.048 | 0.04 | |
GSH-PX | 303.82 | 312.86 | 295.83 | 304.95 | 18.79 | 0.82 | 0.85 | 0.99 | |
CAT (U/mL) | 52.1 | 57.3 | 47.63 | 53.83 | 3.61 | 0.46 | 0.61 | 0.95 | |
T-SOD (U/mL) | 409.22 a | 347.16 ab | 297.27 b | 307.46 b | 13.58 | 0.25 | <0.01 | 0.12 | |
Ileum | MDA (nmol/mL) | 1.82 b | 1.77 b | 2.64 a | 1.30 b | 0.15 | <0.01 | 0.45 | 0.01 |
T-AOC (U/mL) | 0.38 b | 0.59 a | 0.27 b | 0.35 b | 0.03 | 0.01 | <0.01 | 0.24 | |
GSH-PX | 201.69 ab | 215.34 ab | 175.60 b | 223.13 a | 7.61 | 0.04 | 0.53 | 0.25 | |
CAT (U/mL) | 44.35 ab | 50.23 a | 28.79 c | 32.11 bc | 2.73 | 0.31 | <0.01 | 0.77 | |
T-SOD (U/mL) | 122.06 c | 165.63 a | 116.13 c | 148.87 b | 4.76 | <0.01 | 0.01 | 0.21 |
MDA, Malondialdehyde; T-AOC, total antioxidant capacity; GSH-Px, Glutathione peroxidase; CAT, catalase; T-SOD, total superoxide dismutase. Values within a row with different letters differ significantly (p < 0.05).